Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol.


Journal

Journal of stomatology, oral and maxillofacial surgery
ISSN: 2468-7855
Titre abrégé: J Stomatol Oral Maxillofac Surg
Pays: France
ID NLM: 101701089

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 16 06 2019
accepted: 21 06 2019
pubmed: 5 7 2019
medline: 25 9 2020
entrez: 5 7 2019
Statut: ppublish

Résumé

Osteoradionecrosis of the jaws (ORNJ) is a late complication of head and neck irradiation estimated at around 3% of irradiated patients. The PENTO protocol (Pentoxyfilline and Tocopherol), with the eventual adjunction of Clodronate (PENTOCLO), showed interesting results even in advanced ORNJ. The current literature does not describe the long-term outcomes and particularly after the completion of the protocol. The PENTO or PENTOCLO protocol should be prescribed as a life-long treatment or the outcome should be monitored at least as long as the duration of the protocol after its end.

Identifiants

pubmed: 31271892
pii: S2468-7855(19)30163-6
doi: 10.1016/j.jormas.2019.06.007
pii:
doi:

Substances chimiques

Drug Combinations 0
pentoxifylline-tocopherol-clodronate 0
Clodronic Acid 0813BZ6866
Tocopherols R0ZB2556P8
Pentoxifylline SD6QCT3TSU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

286-287

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

A Dinnoo (A)

Department of Head and Neck Oncology, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France.

F Bidault (F)

Department of Radiology, Institut Gustave-Roussy, 14, rue Édouard Vaillant, 94800 Villejuif, France; IR4M, UMR 8081, CNRS, université Paris-Sud, université Paris-Saclay, 91400 Orsay, France.

N Lassau (N)

Department of Radiology, Institut Gustave-Roussy, 14, rue Édouard Vaillant, 94800 Villejuif, France; IR4M, UMR 8081, CNRS, université Paris-Sud, université Paris-Saclay, 91400 Orsay, France.

M Elmaalouf (M)

Department of Odontology, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France.

A Moya-Plana (A)

Department of Head and Neck Oncology, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France.

A Ruffier (A)

Department of Radiotherapy, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France.

F Janot (F)

Department of Head and Neck Oncology, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France.

N Benmoussa (N)

Department of Head and Neck Oncology, Gustave Roussy Institute, université Paris-Saclay, 14, rue Édouard Vaillant, 94800 Villejuif, France. Electronic address: nadia.benmoussa@yahoo.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH